Skip to main content

RENAISSANCERE HOLDINGS LTD

For the period ended Dec 31, 2025. Filed Feb 11, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 11, 2026

RNR$347.35-1.9%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Capital Resources

We monitor our capital adequacy on a regular basis and seek to adjust our capital according to the needs of our business. In particular, we require capital sufficient to meet or exceed the capital adequacy ratios established by rating agencies for maintenance of appropriate financial strength ratings, the capital adequacy tests performed by regulatory authorities and the capital requirements under our credit facilities. From time to time, rating agencies may make changes in their capital models and rating methodologies, which could increase the amount of capital required to support our ratings. We may seek to raise additional capital or return capital to our shareholders through common share repurchases and cash dividends (or a combination of such methods). In the normal course of our operations, we may from time to time evaluate additional share or debt issuances given prevailing market conditions and capital management strategies, including for our operating subsidiaries, joint ventures and managed funds. In addition, as noted above, we enter into agreements with financial institutions to obtain letter of credit facilities for the benefit of our operating subsidiaries and certain of our joint ventures and managed funds in their reinsurance and insurance business.

Our total shareholders’ equity attributable to RenaissanceRe and total debt was as follows:

At December 31,20252024Change
(in thousands)
Common shareholders’ equity$10,858,657$9,824,012$1,034,645
Preference shares750,000750,000—
Total shareholders’ equity attributable to RenaissanceRe$11,608,657$10,574,012$1,034,645
7.003% Senior Notes due 2035 (Fontana) (1)$99,224$—$99,224
5.950% Senior Notes due 2035 (DaVinci) (2)296,972—296,972
5.800% Senior Notes due 2035493,770—493,770
5.750% Senior Notes due 2033743,009742,068941
3.600% Senior Notes due 2029396,966396,051915
3.450% Senior Notes due 2027299,260298,765495
3.700% Senior Notes due 2025 (3)—299,908(299,908)
4.750% Senior Notes due 2025 (DaVinci) (2)(4)—149,897(149,897)
Total senior notes2,329,2011,886,689442,512
Medici Revolving Credit Facility (5)———
Total debt$2,329,201$1,886,689$442,512

(1) RenaissanceRe owns a noncontrolling economic interest in its joint venture Fontana. Because RenaissanceRe controls a majority of Fontana’s issued voting shares, the consolidated financial statements of Fontana are included in the consolidated financial statements of RenaissanceRe. RenaissanceRe has not provided any financial or other support to Fontana that it was not contractually required to provide. RenaissanceRe’s financial exposure to Fontana is limited to its investment in Fontana’s shares and counterparty credit risk arising from reinsurance transactions.

(2) RenaissanceRe owns a noncontrolling economic interest in its joint venture DaVinci. Because RenaissanceRe controls a majority of DaVinci’s issued voting shares, the consolidated financial statements of DaVinci are included in the consolidated financial statements of RenaissanceRe. However, RenaissanceRe does not guarantee or provide credit support for DaVinci and RenaissanceRe’s financial exposure to DaVinci is limited to its investment in DaVinci’s shares and counterparty credit risk arising from reinsurance transactions.

(3) The 3.700% Senior Notes due 2025 were repaid in full at maturity on April 1, 2025.

(4) The 4.750% Senior Notes due 2025 (DaVinci) were repaid in full at maturity on May 1, 2025.

(5) RenaissanceRe owns a noncontrolling economic interest in Medici. Because RenaissanceRe controls all of Medici’s issued voting shares, the financial statements of Medici are included in RenaissanceRe’s consolidated financial statements. On December 18, 2025, the Medici Revolving Credit Facility was terminated.

Our total shareholders’ equity attributable to RenaissanceRe increased $1.0 billion during 2025 principally as a result of:

our comprehensive income attributable to RenaissanceRe of $2.7 billion; partially offset by

the repurchase of our common shares at an aggregate cost of $1.6 billion; and

$74.8 million of dividends on our common shares and $35.4 million of dividends on our preference shares.

For additional information related to the terms of our debt and significant credit facilities, see “Note 9. Debt and Credit Facilities” in our “Notes to the Consolidated Financial Statements.” See “Note 12. Shareholders’ Equity” in our “Notes to the Consolidated Financial Statements” for additional information related to our common and preference shares.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.